STAT subtype specificity and ischemic preconditioning in mice: is STAT-3 enough?
Open Access
- 1 February 2011
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 300 (2) , H522-H526
Abstract
The role of other STAT subtypes in conferring ischemic tolerance is unclear. We hypothesized that in STAT-3 deletion alternative STAT subtypes would protect myocardial function against ischemia-reperfusion injury. Wild-type (WT) male C57BL/6 mice or mice with cardiomyocyte STAT-3 knockout (KO) underwent baseline echocardiography. Langendorff-perfused hearts underwent ischemic preconditioning (IPC) or no IPC before ischemia-reperfusion. Following ex vivo perfusion, hearts were analyzed for STAT-5 and -6 phosphorylation by Western blot analysis of nuclear fractions. Echocardiography and postequilibration cardiac performance revealed no differences in cardiac function between WT and KO hearts. Phosphorylated STAT-5 and -6 expression was similar in WT and KO hearts before perfusion. Contractile function in WT and KO hearts was significantly impaired following ischemia-reperfusion in the absence of IPC. In WT hearts, IPC significantly improved the recovery of the maximum first derivative of developed pressure (+dP/dtmax) compared with that in hearts without IPC. IPC more effectively improved end-reperfusion dP/dtmax in WT hearts compared with KO hearts. Preconditioned and nonpreconditioned KO hearts exhibited increased phosphorylated STAT-5 and -6 expression compared with WT hearts. The increased subtype activation did not improve the efficacy of IPC in KO hearts. In conclusion, baseline cardiac performance is preserved in hearts with cardiac-restricted STAT-3 deletion. STAT-3 deletion attenuates preconditioning and is not associated with a compensatory upregulation of STAT-5 and -6 subtypes. The activation of STAT-5 and -6 in KO hearts following ischemic challenge does not provide functional compensation for the loss of STAT-3. JAK-STAT signaling via STAT-3 is essential for effective IPC.Keywords
This publication has 22 references indexed in Scilit:
- Regulating RISK: a role for JAK-STAT signaling in postconditioning?American Journal of Physiology-Heart and Circulatory Physiology, 2008
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5BGenes & Development, 2008
- Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signalingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Role of the JAK–STAT pathway in myocardial injuryTrends in Molecular Medicine, 2007
- Role of MAPKs in development and differentiation: lessons from knockout miceBiochimie, 2006
- STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardiumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: Further evidence for the inflammatory basis of atherosclerosisAmerican Heart Journal, 2005
- Pressure Overload Induces Cardiac Dysfunction and Dilation in Signal Transducer and Activator of Transcription 6–Deficient MiceCirculation, 2004
- Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioningCardiovascular Research, 2004